Results 311 to 320 of about 883,236 (393)

Use of ReCross to Increase Success Rate With Antegrade CTO PCI—A Multicenter Observational Study

Catheterization and Cardiovascular Interventions, Volume 106, Issue 1, Page 654-662, July 1, 2025.
ABSTRACT Background Antegrade approach remains one of the predominant techniques for CTO PCI. Success rates have increased significantly recently due to advancements in devices and strategies, along with the hybrid algorithm. ReCross is a uniquely modified microcatheter with two over‐the‐wire lumens and three exit ports, offering significant potential ...
Mohamed Ayoub, Abdul Mozid, Legate Philip, Xavier Millan, Jaikirshan Khatri, Claudiu Ungureanu, Johan Bennett, Chadi Ghafari, Alexandre Avran   +8 more
wiley   +1 more source

Impact of BMI on Recovery and Quality of Life Post-Revascularization in Peripheral Arterial Disease Patients. [PDF]

Med Sci Monit
Nowaczyk A, Cwajda-Białasik J, Szewczyk MT.   +2 more
europepmc   +1 more source

Continuation Versus Interruption of Oral Anticoagulation During TAVI: A Systematic Review and Meta‐Analysis Oral Anticoagulation Management in TAVI

Catheterization and Cardiovascular Interventions, Volume 106, Issue 1, Page 644-653, July 1, 2025.
ABSTRACT Patients undergoing transcatheter aortic valve implantation (TAVI) often require long‐term oral anticoagulation (OAC), but it is unclear whether to continue or interrupt OAC during the procedure. This meta‐analysis compares clinical outcomes of continuing versus interrupting OAC during TAVI.
Jefferson Manoel Borges Martins, Rafael dos Santos Borges, Giovanni Gosch Berton, Paula Larissa Ferreira Vieira, Pedro Antônio Machado Gomes de Sousa, Ana Livia Chaves Vieira, Christian Ken Fukunaga, Vanessa Karlinski Vizentin, Esthefani Monique Rodrigues Macedo, Camila Mota Guida   +9 more
wiley   +1 more source

Toe-brachial index and toe systolic blood pressure for the diagnosis of peripheral arterial disease. [PDF]

Cochrane Database Syst Rev
Tehan PE, Mills J, Leask S, Oldmeadow C, Peterson B, Sebastian M, Chuter V.   +6 more
europepmc   +1 more source

Increased Thrombogenicity is Associated With Coronary Microvascular Dysfunction in Patients With STEMI—A Proof‐of‐Concept Study

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Up to 50% of patients with ST‐segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI) develop coronary microvascular dysfunction (CMD). Aims This study aims to assess whether a prothrombotic state of coronary blood, defined by thromboelastography (TEG), is associated with post ...
Roberto Scarsini, Denis Leonardi, Andrea Bottardi, Concetta Mammone, Leonardo Portolan, Caterina Butturini, Verdiana Galli, Francesco Della Mora, Alessandro Ruzzarin, Sara Pazzi, Anna Piccoli, Simone Fezzi, Domenico Tavella, Gabriele Pesarini, Leonardo Gottin, Flavio Ribichini   +15 more
wiley   +1 more source

Serum Trimethylamine N-Oxide Levels as a Predictor of Peripheral Arterial Disease in Kidney Transplant Recipients. [PDF]

Med Sci Monit
Yang HH, Chen YC, Liu CH, Hsu BG.
europepmc   +1 more source

Treatment With Phosphodiesterase 5 Inhibitors and Long‐Term Outcomes in Patients Undergoing Coronary Angiography and Cardiac Catheterization

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The effects of phosphodiesterase 5 (PDE5) inhibitors on the incidence of long‐term outcomes in patients with cardiovascular disease are not well understood. Objective: We studied the association between PDE5 inhibitor therapy and the incidence of adverse cardiovascular major adverse cardiovascular events (MACE) in patients ...
Sumon Roy, Annette Min, Edward O. McFalls, Robert A. Perera, Fadi N. Salloum, Ion S. Jovin   +5 more
wiley   +1 more source

Asymptomatic Peripheral Arterial Disease Among Jordanian Patients With Diabetic Foot Ulcer. [PDF]

Cureus
Abu-Jableh W, Younis A, Hjazeen A, Mashaqbeh E, Al-Sharif E.   +4 more
europepmc   +1 more source

A Case Series of Valve‐in‐Valve Transcatheter Aortic Valve Replacement in Stentless Bioprosthetic Valves Using Self‐Expanding Platform With Minimalist Approach

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Valve‐in‐valve (ViV) Transcatheter aortic valve replacement (TAVR) has emerged as a valid treatment option in symptomatic patients with failed aortic bioprosthetic valves, most especially in those with intermediate, high or prohibitive risk of surgery. Due to the unique design of stentless bioprosthetic valves with absence of visible posts and
Adeogo Akinwale Olusan, Raj Rajendra, Elved Roberts, Jan Kovac   +3 more
wiley   +1 more source

Sirolimus-coated balloons for peripheral arterial disease: walking free into the future of endovascular treatment. [PDF]

Cardiovasc Diagn Ther
Fumagalli RM, Barco S.
europepmc   +1 more source